Literature DB >> 16823310

Relationship of cine phase-contrast magnetic resonance imaging with outcome after decompression for Chiari I malformations.

Matthew J McGirt1, Shahid M Nimjee, Herbert E Fuchs, Timothy M George.   

Abstract

OBJECTIVE: Many patients with symptomatic Chiari I malformations experience symptom recurrence after surgical decompression. Identification of predictors of outcome is needed to better select patients most likely to benefit from surgical intervention. We examined whether or not cerebrospinal fluid (CSF) flow dynamics assessed by cine phase contrast magnetic resonance imaging could independently predict response to posterior fossa decompression for Chiari I malformations.
METHODS: Pre- and postoperative CSF flow dynamics were assessed by cine phase-contrast magnetic resonance imaging in 130 consecutive patients receiving posterior fossa decompression for a Chiari I malformation between 1997 and 2003. CSF flow was classified as "abnormal" if biphasic flow was either absent or decreased through the aqueduct, fourth ventricle and its outlets, the foramen magnum, or ventral or dorsal to the cervical spinal cord. If no evidence of decreased flow was noted, CSF flow was classified as "normal." The association between preoperative CSF flow dynamics, all recorded variables, and long-term outcome was assessed using multivariate proportional hazards regression analysis.
RESULTS: All patients had tonsil herniation more than 5 mm below the foramen magnum (average, 11 +/- 5 mm). Abnormal hindbrain CSF flow was observed in 81% of patients (43% complete obstruction, 38% reduced flow). Normal CSF flow was observed in 19% of patients. In multivariate analysis, patients with normal preoperative hindbrain CSF flow were 4.8-fold more likely to experience symptom recurrence after surgery (relative risk, 4.85; 95% confidence interval, 1.88-12.5; P < 0.001) regardless of degree of tonsillar ectopia or presence of syringomyelia. Isolated frontal headache (relative risk, 4.16; 95% confidence interval, 1.7-9.8; P < 0.05) and scoliosis (relative risk, 9.2; 95% confidence interval, 1.7-10.5; P < 0.001) also were independent risk factors for symptom recurrence.
CONCLUSION: Normal preoperative hindbrain CSF flow was an independent risk factor for treatment failure after decompression for Chiari I malformation regardless of the degree of tonsillar ectopia. Cine phase-contrast magnetic resonance imaging may be a valuable tool in identifying patients who are less likely to respond to surgical decompression for Chiari I malformation.

Entities:  

Mesh:

Year:  2006        PMID: 16823310     DOI: 10.1227/01.NEU.0000219841.73999.B3

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  27 in total

Review 1.  Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis.

Authors:  Izumi Koyanagi; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2010-06-08       Impact factor: 3.042

2.  Magnetic resonance 4D flow analysis of cerebrospinal fluid dynamics in Chiari I malformation with and without syringomyelia.

Authors:  Alexander C Bunck; Jan Robert Kroeger; Alena Juettner; Angela Brentrup; Barbara Fiedler; Gerard R Crelier; Bryn A Martin; Walter Heindel; David Maintz; Wolfram Schwindt; Thomas Niederstadt
Journal:  Eur Radiol       Date:  2012-05-09       Impact factor: 5.315

Review 3.  Cerebrospinal fluid flow imaging by using phase-contrast MR technique.

Authors:  B Battal; M Kocaoglu; N Bulakbasi; G Husmen; H Tuba Sanal; C Tayfun
Journal:  Br J Radiol       Date:  2011-05-17       Impact factor: 3.039

4.  Surgical management of Chiari I malformation based on different cerebrospinal fluid flow patterns at the cranial-vertebral junction.

Authors:  Tao Fan; HaiJun Zhao; XinGang Zhao; Cong Liang; YinQian Wang; QiFei Gai
Journal:  Neurosurg Rev       Date:  2017-02-09       Impact factor: 3.042

5.  Tonsillar pulsatility before and after surgical decompression for children with Chiari malformation type 1: an application for true fast imaging with steady state precession.

Authors:  Alireza Radmanesh; Jacob K Greenberg; Arindam Chatterjee; Matthew D Smyth; David D Limbrick; Aseem Sharma
Journal:  Neuroradiology       Date:  2015-01-07       Impact factor: 2.804

6.  Phase-contrast cerebrospinal fluid flow magnetic resonance imaging in qualitative evaluation of patency of CSF flow pathways prior to infusion of chemotherapeutic and other agents into the fourth ventricle.

Authors:  Rajan P Patel; Clark W Sitton; Leena M Ketonen; Ping Hou; Jason M Johnson; Seferino Romo; Stephen Fletcher; Manish N Shah; Marcia Kerr; Wafik Zaky; Michael E Rytting; Soumen Khatua; David I Sandberg
Journal:  Childs Nerv Syst       Date:  2017-11-23       Impact factor: 1.475

7.  The Chiari Severity Index: a preoperative grading system for Chiari malformation type 1.

Authors:  Jacob K Greenberg; Chester K Yarbrough; Alireza Radmanesh; Jakub Godzik; Megan Yu; Donna B Jeffe; Matthew D Smyth; Tae Sung Park; Jay F Piccirillo; David D Limbrick
Journal:  Neurosurgery       Date:  2015-03       Impact factor: 4.654

8.  Treatment of symptomatic Chiari I malformation by "all-factors-surgery": a report of 194 cases.

Authors:  Weihua Chu; Xin Chen; Xingsen Xue; Guangjian He; Jingjing Liu; Hongyan Zhang; Hua Feng; Jiangkai Lin
Journal:  Eur Spine J       Date:  2021-02-22       Impact factor: 3.134

9.  Correlation of hindbrain CSF flow and outcome after surgical decompression for Chiari I malformation.

Authors:  Matthew J McGirt; April Atiba; Frank J Attenello; Bruce A Wasserman; Ghazala Datoo; Muraya Gathinji; Benjamin Carson; John D Weingart; George I Jallo
Journal:  Childs Nerv Syst       Date:  2008-01-19       Impact factor: 1.475

10.  Suboccipital decompression for Chiari I malformation: outcome comparison of duraplasty with expanded polytetrafluoroethylene dural substitute versus pericranial autograft.

Authors:  Frank J Attenello; Matthew J McGirt; Giannina L Garcés-Ambrossi; Kaisorn L Chaichana; Benjamin Carson; George I Jallo
Journal:  Childs Nerv Syst       Date:  2008-09-04       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.